What is the current Price Target for the Repare Therapeutics Inc stock?

The average Repare Therapeutics Inc target price is $6.63. This is 360.42% higher than the current stock price. The highest price target is 483.33%, the lowest is 250.69%. 4 Analysts have issued a price target Repare Therapeutics Inc 2026 .

How high will the Repare Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Repare Therapeutics Inc stock will rise. The performance of stocks, including the Repare Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Repare Therapeutics Inc stock today?

The performance of Repare Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Repare Therapeutics Inc stock fall?

The decline in Repare Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Repare Therapeutics Inc Forecast, price target & analysts

$1.44

0.00%

Nasdaq, Jul 03, 07:00 pm CET

ISIN

US7602731025

Symbol

RPTX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Repare Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Repare Therapeutics Inc Classifications & Recommendation:

Buy

70%

Hold

30%

Repare Therapeutics Inc Price Target

Target Price	$6.63
Price	$1.44
Potential	360.42% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target Repare Therapeutics Inc 2026 . The average Repare Therapeutics Inc target price is $6.63. This is 360.42% register free of charge higher than the current stock price. The highest price target is $8.40 483.33% register free of charge , the lowest is $5.05 250.69% register free of charge .
	A rating was issued by 10 analysts: 7 Analysts recommend Repare Therapeutics Inc to buy, 3 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Repare Therapeutics Inc stock has an average upside potential 2026 of 360.42% register free of charge . Most analysts recommend the Repare Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-2.00	-2.15
	10.31%	7.50%
P/E		negative

4 Analysts have issued a Repare Therapeutics Inc forecast for earnings per share. The average Repare Therapeutics Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-2.00	10.31%
2025	$-2.15 7.50% Unlock
2026	$-1.58 26.51% Unlock
2027	$-2.40 51.90% Unlock
2028	$-2.85 18.75% Unlock
2029	$-3.85 35.09% Unlock

Current	-0.48	85.07%
2025	-0.67 40.05% Unlock
2026	-0.91 35.82% Unlock
2027	-0.60 34.07% Unlock

Repare Therapeutics Inc...

Current Repare Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 07 2025
LifeSci Capital	Locked ➜ Locked	Locked	Dec 13 2024
Stifel	Locked ➜ Locked	Locked	Dec 13 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 08 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 24 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 23 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 04 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 07 2025
Locked LifeSci Capital: Locked ➜ Locked	Dec 13 2024
Locked Stifel: Locked ➜ Locked	Dec 13 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 08 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 24 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 23 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 04 2024

Discover more stocks with a high price target

Alibaba Group Holding Ltd 54.63%

Tencent Holdings Ltd. 29.02%

BioNTech SE - ADR 27.50%

Deutsche Telekom 25.72%

Siemens 15.22%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now